Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Kimberly P. Dunsmore(University of Virginia), Stephen P. Hunger(Children's Hospital of Philadelphia), Nancy Eisenberg(University of New Mexico), Karen R. Rabin(Baylor College of Medicine), Mignon L. Loh(University of California, San Francisco), Brent L. Wood(University of Washington), Robert J. Hayashi(St. Louis Children's Hospital), Elizabeth A. Raetz(NYU Langone Health), Naomi Winick(The University of Texas Southwestern Medical Center), Nikki Briegel(Princess Margaret Hospital for Children), Kirk R. Schultz(University of British Columbia), Stuart S. Winter(Children’s Minnesota - St. Paul Hospital), Barbara L. Asselin(University of Rochester Medical Center), Andrew J. Carroll(University of Alabama at Birmingham), William L. Carroll(NYU Langone Health), Natia Esiashvili(Emory University), Meenakshi Devidas(National Institutes of Health), Zhiguo Chen(University of Florida), Patrick A. Zweidler‐McKay(The University of Texas MD Anderson Cancer Center), Nyla A. Heerema(The Ohio State University), Julie M. Gastier‐Foster(Nationwide Children's Hospital)
Cited by 254
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k